Mark P. Carthy

Fondateur chez Orion Equity Partners LLC

Profil

Mark P.
Carthy is the founder of Orion Equity Partners LLC, serving as Managing Partner since 2008.
Mr. Carthy is the founder of AnTolRx, Inc., serving as Chief Executive Officer & Director since 2015.
Mr. Carthy is also the founder of Faraday Pharmaceuticals, Inc. (Washington).
Former positions include President, Chief Executive Officer & Director at Savran Technologies, Inc.; Chairman at Artesian Therapeutics, Inc.; Chairman at Cyberkinetics Neurotechnology Systems, Inc. from 2002 to 2008; Director at Dendreon Corp.; Director at Dynogen Pharmaceuticals, Inc.; Director at Ensemble Therapeutics Corp.; Director at ImpactRx, Inc.; Director at Variagenics, Inc.; Director at Astex Therapeutics Ltd.; Non-Executive Director at PowderMed Ltd.; Director at Antisoma, Inc.; Director at Solexa, Inc.; Independent Director at Rexahn Pharmaceuticals, Inc. from 2014 to 2018; Director at 1efficiency, Inc.; Chief Business Officer at Cubist Pharmaceuticals LLC; General Partner at Oxford Bioscience Partners from 2000 to 2007; Principal at Morningside Venture Group LLC.
Education includes a graduate degree from the University of Missouri conferred in 1983, an undergraduate degree from University College Dublin conferred in 1982, and an MBA from Harvard Business School conferred in 1987.

Postes actifs de Mark P. Carthy

Sociétés	Poste	Début
Orion Equity Partners LLC	Fondateur	01/01/2008
Antolrx, Inc.	Fondateur	01/01/2015

Anciens postes connus de Mark P. Carthy

Sociétés	Poste	Fin
REXAHN PHARMACEUTICALS, INC.	Directeur/Membre du Conseil	14/06/2018
PowderMed Ltd.	Directeur/Membre du Conseil	15/05/2008
Cyberkinetics Neurotechnology Systems, Inc.	Président	18/04/2008
Oxford Bioscience Partners	Private Equity Investor	31/10/2007
Solexa, Inc.	Directeur/Membre du Conseil	26/01/2007